C. Soh

435 total citations
11 papers, 357 citations indexed

About

C. Soh is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, C. Soh has authored 11 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in C. Soh's work include Lung Cancer Treatments and Mutations (4 papers), Lung Cancer Diagnosis and Treatment (3 papers) and Lung Cancer Research Studies (3 papers). C. Soh is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Lung Cancer Diagnosis and Treatment (3 papers) and Lung Cancer Research Studies (3 papers). C. Soh collaborates with scholars based in Australia, Singapore and United Kingdom. C. Soh's co-authors include Fairooz F. Kabbinavar, Julian Thumboo, Paula G. O’Connor, V. A. Miller, B. E. Johnson, V.A. Miller, Cynthia Bin Eng Chee, Irving Charles Boudville, S P Chan and David Machin and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Respiratory and Critical Care Medicine and European Heart Journal.

In The Last Decade

C. Soh

9 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Soh Australia	7	165	143	91	74	51	11	357
Mary Choroszy United States	9	66 0.4×	85 0.6×	33 0.4×	15 0.2×	38 0.7×	14	298
Georges Mjaess Lebanon	9	76 0.5×	76 0.5×	95 1.0×	43 0.6×	37 0.7×	51	337
Lisa Lawrence-Miyasaki United States	5	78 0.5×	169 1.2×	172 1.9×	69 0.9×	12 0.2×	7	458
N. Bissada United States	8	125 0.8×	45 0.3×	85 0.9×	31 0.4×	79 1.5×	27	299
Hassan Ghoz United States	8	78 0.5×	45 0.3×	149 1.6×	13 0.2×	15 0.3×	47	269
Sarah Kamel United States	9	41 0.2×	43 0.3×	80 0.9×	28 0.4×	26 0.5×	26	271
Yoshitaka Kuroda Japan	8	145 0.9×	138 1.0×	169 1.9×	16 0.2×	29 0.6×	27	320
Lucian Negreanu Romania	12	88 0.5×	106 0.7×	185 2.0×	8 0.1×	27 0.5×	64	410
Xuwei Hong China	9	51 0.3×	45 0.3×	119 1.3×	9 0.1×	43 0.8×	21	233

Countries citing papers authored by C. Soh

Since Specialization

Citations

This map shows the geographic impact of C. Soh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Soh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Soh more than expected).

Fields of papers citing papers by C. Soh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Soh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Soh. The network helps show where C. Soh may publish in the future.

Co-authorship network of co-authors of C. Soh

This figure shows the co-authorship network connecting the top 25 collaborators of C. Soh. A scholar is included among the top collaborators of C. Soh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Soh. C. Soh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Soh, C., et al.. (2024). An Artificial Intelligence-Guided Echocardiography in Primary Care Patients from Rural and Remote Communities: The AGILE-Echo Study. Heart Lung and Circulation. 33. S161–S161. 1 indexed citations

2.

Soh, C. & Thomas H. Marwick. (2024). Comparison of cardiovascular disease risk assessment tools for heart failure prediction among cancer patients. European Heart Journal. 45(Supplement_1). 1 indexed citations

3.

Wong, Joshua, Quan Huynh, C. Soh, Julian A. Smith, & Thomas H. Marwick. (2024). Cancer survivorship - heart failure risk factor or potentiator?. European Heart Journal. 45(Supplement_1).

4.

Kabbinavar, Fairooz F., et al.. (2010). Overall survival (OS) in ATLAS, a phase IIIb trial comparing bevacizumab (B) therapy with or without erlotinib (E) after completion of chemotherapy (chemo) with B for first-line treatment of locally advanced, recurrent, or metastatic non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 28(15_suppl). 7526–7526. 90 indexed citations

5.

Miller, V. A., Paula G. O’Connor, C. Soh, & Fairooz F. Kabbinavar. (2009). A randomized, double-blind, placebo-controlled, phase IIIb trial (ATLAS) comparing bevacizumab (B) therapy with or without erlotinib (E) after completion of chemotherapy with B for first-line treatment of locally advanced, recurrent, or metastatic non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 27(18_suppl). LBA8002–LBA8002. 54 indexed citations

6.

Hopkins, C. A., et al.. (2009). Severe reversible chorea complicating non‐ketotic hyperglycaemia. Practical Diabetes International. 26(8). 331–331.

7.

Johnson, Bruce E., et al.. (2009). 8LBA Biomarker evaluation in the randomized, double-blind, placebo-controlled, Phase IIIb ATLAS Trial, comparing bevacizumab (B) therapy with or without erlotinib (E), after completion of chemotherapy with B for the treatment of locally-advanced, recurrent, or metastatic non-small cell lung cancer (NSCLC). European Journal of Cancer Supplements. 7(3). 5–6. 15 indexed citations

8.

Miller, V. A., Paula G. O’Connor, C. Soh, & Fairooz F. Kabbinavar. (2009). A randomized, double-blind, placebo-controlled, phase IIIb trial (ATLAS) comparing bevacizumab (B) therapy with or without erlotinib (E) after completion of chemotherapy with B for first-line treatment of locally advanced, recurrent, or metastatic non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 27(18S). LBA8002–LBA8002. 17 indexed citations

9.

Thumboo, Julian, S P Chan, David Machin, et al.. (2002). Measuring Health-related Quality of Life in Singapore: Normal Values for the English and Chinese SF-36 Health Survey. Annals of the Academy of Medicine Singapore. 31(3). 366–374. 41 indexed citations

10.

Chee, Cynthia Bin Eng, et al.. (2001). Interpretation of the Tuberculin Skin Test in Mycobacterium bovis BCG-vaccinated Singaporean Schoolchildren. American Journal of Respiratory and Critical Care Medicine. 164(6). 958–961. 50 indexed citations

11.

Thumboo, Julian, et al.. (2001). Validation of the Western Ontario and McMaster University Osteoarthritis Index in Asians with Osteoarthritis in Singapore. Osteoarthritis and Cartilage. 9(5). 440–446. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact